.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Cipla
QuintilesIMS
Moodys
Queensland Health
Fish and Richardson
Colorcon
US Army
AstraZeneca
Merck

Generated: July 22, 2017

DrugPatentWatch Database Preview

PEMOLINE Drug Profile

« Back to Dashboard

Which patents cover Pemoline, and when can generic versions of Pemoline launch?

Pemoline is a drug marketed by Mallinckrodt, Vintage Pharms, Teva Pharms, Actavis Elizabeth, Sandoz, and Watson Labs. and is included in eight NDAs.

The generic ingredient in PEMOLINE is pemoline. There are seven drug master file entries for this compound. Additional details are available on the pemoline profile page.

Summary for Tradename: PEMOLINE

Patents:0
Applicants:6
NDAs:8
Bulk Api Vendors: see list32
Clinical Trials: see list5
Patent Applications: see list2,531
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PEMOLINE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mallinckrodt
PEMOLINE
pemoline
TABLET;ORAL075726-003Mar 30, 2001DISCNNoNo► Subscribe► Subscribe
Actavis Elizabeth
PEMOLINE
pemoline
TABLET;ORAL075595-001Feb 28, 2000DISCNNoNo► Subscribe► Subscribe
Teva Pharms
PEMOLINE
pemoline
TABLET;ORAL075030-003Feb 22, 2000DISCNNoNo► Subscribe► Subscribe
Vintage Pharms
PEMOLINE
pemoline
TABLET;ORAL075328-001Apr 19, 2000DISCNNoNo► Subscribe► Subscribe
Sandoz
PEMOLINE
pemoline
TABLET;ORAL075286-001Dec 27, 1999DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Harvard Business School
Dow
McKinsey
Queensland Health
Moodys
Teva
Mallinckrodt
Accenture
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot